niacinamide has been researched along with hydrazine in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (29.17) | 18.7374 |
1990's | 1 (4.17) | 18.2507 |
2000's | 7 (29.17) | 29.6817 |
2010's | 9 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Halbhübner, K; Herken, H; Kehr, W; Loos, D | 1 |
Nestler, HJ | 1 |
Das, S; Duraiswami, PK; Narayanan, I; Sriramachari, S | 1 |
Celechovský, J; Greksáková, O | 1 |
Lehmann, A; Mandel, P; Simler, S | 1 |
Baldessarini, RJ | 1 |
Bender, DA | 1 |
Boerman, OC; Corstens, FH; Dams, ET; Koenders, EB; Laverman, P; Oyen, WJ; Prevost, R; Storm, G; van der Meer, JW | 1 |
Boerman, OC; Corstens, FH; Koenders, EB; Oyen, WJ; Rennen, HJ | 1 |
Boerman, OC; Corstens, FH; Gratz, S; Oyen, WJ; Rennen, HJ | 1 |
Boersma, HH; Deckers, NM; Heidendal, GA; Hofstra, L; Kenis, H; Reutelingsperger, CP; Stolk, LM; Vanderheyden, JL | 1 |
Mikiciuk-Olasik, E; Szymański, P; Zurek, E | 1 |
Boerman, OC; Corstens, FH; Laverman, P; Oyen, WJ; Rennen, HJ; van Eerd, JE | 1 |
Duatti, A; Faintuch, BL; Faintuch, S; Muramoto, E; Smith, CJ; Teodoro, R | 1 |
Biagini, S; Blower, PJ; King, R; Mather, SJ; Surfraz, MB | 1 |
Aguado, P; Belda, JE; Colomer, I; Fereres, A; Heredia, RM; Medina, P; Viñuela, E | 1 |
Liu, B; Mou, T; Shao, G; Wang, F; Yang, W; Zhang, X | 1 |
Bailly, C; Guilbaud, N; Guminski, Y; Imbert, T; Kruczynski, A; Le Pape, A; Lerondel, S; Pesnel, S; Pillon, A | 1 |
Avcı, CB; Durkan, K; Gündüz, C; Ozgür, A; Susluer, SY; Yurt Lambrecht, F | 1 |
Abedi, SM; Hosseinimehr, SJ; Noaparast, Z; Varmira, K | 1 |
Chen, X; Feng, Z; Li, C; Li, Y; Niu, F; Tang, K; Yang, H; Zhang, L; Zhou, W | 1 |
Fukunaga, K; Iwasaki, K; Kohno, K; Kurokawa, T; Murata, S; Ohkohchi, N; Zheng, YW | 1 |
Abedi, SM; Ahmadpour, S; Hosseinimehr, SJ; Noaparast, Z | 1 |
Arribas, AJ; Bertoni, F; Cascione, L; Curti, E; Gaudio, E; Priebe, V; Rossi, D; Spriano, F; Stathis, A; Tarantelli, C; Zhang, L; Zucca, E | 1 |
24 other study(ies) available for niacinamide and hydrazine
Article | Year |
---|---|
Impaired dopamine function and muscular rigidity induced by 6-aminonicotinamide in rats.
Topics: 6-Aminonicotinamide; Animals; Brain Chemistry; Catecholamines; Dopamine; Hydrazines; Male; Methyltyrosines; Muscle Rigidity; Niacinamide; Rats; Time Factors | 1978 |
[Chemical studies the mechanism of action of isoniazid].
Topics: Amides; Bacteria; Catalase; Chelating Agents; Chemistry, Pharmaceutical; Heterocyclic Compounds; Hydrazines; Hydrogen Peroxide; Isoniazid; Isonicotinic Acids; Mycobacterium; Niacinamide; Oxidation-Reduction; Porphyrins | 1966 |
Experimentally induced myopathy in chick and its comparison with muscular dystrophy in children.
Topics: Animals; Chick Embryo; Child; Humans; Hydrazines; Muscular Diseases; Muscular Dystrophies; Niacinamide | 1970 |
[Spectral study of pyridine carboxylic acid amides and hydrazides].
Topics: Humans; Hydrazines; Mycobacterium tuberculosis; Niacinamide; Spectrophotometry; Ultraviolet Rays | 1970 |
[Protection against audiogenic crises in mice by nicotinamide].
Topics: Age Factors; Aminobutyrates; Animals; Coenzymes; Hearing Loss, Noise-Induced; Hydrazines; Mice; NAD; Niacinamide; Pyridoxal Phosphate | 1967 |
Alterations in tissue levels of S-adenosylmethionine.
Topics: Adrenal Glands; Animals; Brain; Carbon Isotopes; Cycloparaffins; Female; Hydrazines; Iproniazid; Ketones; Kidney; Liver; Lung; Male; Methionine; Myocardium; Niacinamide; Pargyline; Pyrogallol; Radioisotope Dilution Technique; Rats; Spleen; Tranylcypromine | 1966 |
Effects of benserazide, carbidopa and isoniazid administration on tryptophan-nicotinamide nucleotide metabolism in the rat.
Topics: Animals; Benserazide; Body Weight; Carbidopa; Diet; Hydrazines; Isoniazid; Liver; Male; Niacinamide; Rats; Ribonucleotides; Time Factors; Tryptophan | 1980 |
A novel method to label liposomes with 99mTc by the hydrazino nicotinyl derivative.
Topics: Abscess; Animals; Drug Carriers; Gamma Cameras; Hindlimb; Hydrazines; Liposomes; Male; Niacinamide; Phosphatidylethanolamines; Polyethylene Glycols; Radionuclide Imaging; Rats; Rats, Wistar; Staphylococcal Infections; Technetium; Technetium Tc 99m Exametazime; Tissue Distribution | 1999 |
Labeling proteins with Tc-99m via hydrazinonicotinamide (HYNIC): optimization of the conjugation reaction.
Topics: Aprotinin; Biological Assay; Chromatography, High Pressure Liquid; Cytochrome c Group; Humans; Hydrazines; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-8; Lactalbumin; Leukocytes; Muramidase; Niacinamide; Proteins; Receptors, Immunologic; Sialoglycoproteins; Technetium | 2000 |
Rapid imaging of experimental colitis with (99m)Tc-interleukin-8 in rabbits.
Topics: Acute Disease; Animals; Colitis; Colon; Female; Gamma Cameras; Granulocytes; Hydrazines; Interleukin-8; Niacinamide; Rabbits; Radionuclide Imaging; Radiopharmaceuticals; Technetium; Technetium Tc 99m Exametazime; Trinitrobenzenesulfonic Acid | 2001 |
The ApoCorrect assay: a novel, rapid method to determine the biological functionality of radiolabeled and fluorescent Annexin A5.
Topics: Annexin A5; Apoptosis; Binding, Competitive; Biological Assay; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Heating; Humans; Hydrazines; Hydrogen-Ion Concentration; Jurkat Cells; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Microspheres; Niacinamide; Organotechnetium Compounds; Phospholipids; Radiopharmaceuticals; Reproducibility of Results; Technetium | 2004 |
New tacrine-hydrazinonicotinamide hybrids as acetylcholinesterase inhibitors of potential interest for the early diagnostics of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Hydrazines; Indicators and Reagents; Kinetics; Niacinamide; Radiopharmaceuticals; Tacrine; Technetium Compounds | 2006 |
PET imaging of infection with a HYNIC-conjugated LTB4 antagonist labeled with F-18 via hydrazone formation.
Topics: Abscess; Animals; Escherichia coli Infections; Fluorine Radioisotopes; Hydrazines; Hydrazones; Indicators and Reagents; Infections; Isotope Labeling; Leukotriene B4; Muscular Diseases; Niacinamide; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Technetium; Tissue Distribution | 2007 |
Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
Topics: Animals; Bombesin; Cell Line, Tumor; Cysteine; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Drug Stability; Hydrazines; Hydrophobic and Hydrophilic Interactions; Isotope Labeling; Male; Metabolic Clearance Rate; Mice; Niacinamide; Nitrogen Compounds; Organotechnetium Compounds; Pancreas; Phosphines; Prostate; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Bombesin; Tissue Distribution | 2008 |
Technetium-binding in labelled HYNIC-peptide conjugates: role of coordinating amino acids.
Topics: Animals; Cattle; Glutamic Acid; Glycine; Histidine; Hydrazines; Niacinamide; Peptides; Serum Albumin, Bovine; Spectrometry, Mass, Electrospray Ionization; Technetium | 2009 |
Field trial measuring the compatibility of methoxyfenozide and flonicamid with Orius laevigatus Fieber (Hemiptera: Anthocoridae) and Amblyseius swirskii (Athias-Henriot) (Acari: Phytoseiidae) in a commercial pepper greenhouse.
Topics: Animals; Capsicum; Hemiptera; Hydrazines; Insecticides; Juvenile Hormones; Niacinamide; Pest Control, Biological; Thysanoptera | 2011 |
Copolymer-based hepatocyte asialoglycoprotein receptor targeting agent for SPECT.
Topics: Animals; Asialoglycoprotein Receptor; Carrier Proteins; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Galactose; Hepatocytes; Hydrazines; Iodine Radioisotopes; Lactose; Liver; Magnetic Resonance Spectroscopy; Membrane Proteins; Mice; Niacinamide; Polystyrenes; Spectrophotometry, Infrared; Technetium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2011 |
99mTc-HYNIC-spermine for imaging polyamine transport system-positive tumours: preclinical evaluation.
Topics: Animals; Biological Transport; Carrier Proteins; Cell Line, Tumor; Drug Stability; Female; Humans; Hydrazines; Luminescent Measurements; Male; Mice; Molecular Imaging; Neoplasms; Niacinamide; Organotechnetium Compounds; Radiochemistry; Spermine; Tomography, Emission-Computed, Single-Photon | 2011 |
In vitro evaluation of (99m)Tc-EDDA/tricine-HYNIC-Q-Litorin in gastrin-releasing peptide receptor positive tumor cell lines.
Topics: Animals; Bombesin; Cell Line, Tumor; Cysteine; Edetic Acid; Glycine; Humans; Hydrazines; Ligands; Mice; Niacinamide; Oligopeptides; Organotechnetium Compounds; Radiopharmaceuticals; Rats; Receptors, Bombesin | 2013 |
An improved radiolabelled RNA aptamer molecule for HER2 imaging in cancers.
Topics: Animals; Aptamers, Nucleotide; Cell Line, Tumor; Female; Glycine; Humans; Hydrazines; Indicators and Reagents; Ligands; Mice; Mice, Nude; Molecular Imaging; Niacinamide; Ovarian Neoplasms; Radiopharmaceuticals; Receptor, ErbB-2; RNA; Technetium; Tissue Distribution | 2014 |
The molecular mechanisms of a novel multi-kinase inhibitor ZLJ33 in suppressing pancreatic cancer growth.
Topics: Animals; beta Catenin; Blotting, Western; Cell Movement; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Hydrazines; Immunoprecipitation; Mice; Mice, Inbred BALB C; Mice, Nude; Niacinamide; Pancreatic Neoplasms; Phenylurea Compounds; Proliferating Cell Nuclear Antigen; Protein Kinase Inhibitors; Sorafenib; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2015 |
The Eltrombopag antitumor effect on hepatocellular carcinoma.
Topics: Apoptosis; Benzoates; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Drug Synergism; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Hydrazines; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Pyrazoles; Receptors, Thrombopoietin; Sorafenib | 2015 |
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Chelating Agents; Female; Glycine; Humans; Hydrazines; MCF-7 Cells; Mice, Nude; Niacinamide; Oligopeptides; Radionuclide Imaging; Radiopharmaceuticals; Technetium | 2018 |
The Bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) demonstrated synergies with other anti-lymphoma targeted agents.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cell Proliferation; Drug Synergism; Humans; Hydrazines; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Niacinamide; Piperidines; Pyrazoles; Pyrimidines; Sulfonamides; Triazoles; Tumor Cells, Cultured | 2019 |